Amlexanox

Amlexanox
Clinical data
Trade names	Aphthasol
AHFS/Drugs.com	Monograph
MedlinePlus	a601017
Routes of; administration	Topical
ATC code	A01AD07 (WHO) R03DX01 (WHO);
Pharmacokinetic data
Elimination half-life	3.5 hours
Excretion	Renal (17%)
Identifiers
	IUPAC name 2-amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid;
CAS Number	68302-57-8 ;
PubChem CID	2161;
IUPHAR/BPS	7113;
DrugBank	DB01025 ;
ChemSpider	2076 ;
UNII	BRL1C2459K;
KEGG	D01828 ;
ChEBI	CHEBI:31205 ;
ChEMBL	ChEMBL1096 ;
CompTox Dashboard (EPA)	DTXSID2022595 ;
ECHA InfoCard	100.230.878
Chemical and physical data
Formula	C16H14N2O4
Molar mass	298.298 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1c3cc(ccc3Oc2nc(c(cc12)C(=O)O)N)C(C)C;
	InChI InChI=1S/C16H14N2O4/c1-7(2)8-3-4-12-9(5-8)13(19)10-6-11(16(20)21)14(17)18-15(10)22-12/h3-7H,1-2H3,(H2,17,18)(H,20,21) ; Key:SGRYPYWGNKJSDL-UHFFFAOYSA-N ;
	(verify)

Amlexanox (trade name Aphthasol) is an anti-inflammatory antiallergic immunomodulator used to treat recurrent aphthous ulcers (canker sores), and (in Japan) several inflammatory conditions. This drug has been discontinued in the U.S.^[1]

^ "Amlexanox (Aphthasol®)". Archived from the original on 20 November 2013. Retrieved 20 November 2013.